Detalhe da pesquisa
1.
Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study.
Breast Cancer Res Treat
; 195(3): 341-351, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35986801
2.
Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study.
Breast Cancer Res Treat
; 189(1): 269-283, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125341
3.
Effect of delays in initiation of adjuvant endocrine therapy on survival among women with breast cancer.
Breast Cancer Res Treat
; 184(3): 965-975, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32914353
4.
Extended Endocrine Therapy for Early-Stage Breast Cancer: How Do We Decide?
Curr Oncol Rep
; 22(12): 123, 2020 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33015752
5.
Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy.
Breast Cancer Res Treat
; 174(1): 1-13, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30488345
6.
Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study.
Breast Cancer Res Treat
; 171(1): 1-9, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29774470
7.
Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland.
Breast Cancer Res Treat
; 153(3): 573-82, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26364296
8.
Trajectories of parent-adolescent relationship quality among at-risk youth: parental depression and adolescent developmental outcomes.
Arch Psychiatr Nurs
; 29(6): 434-40, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26577559
9.
Accelerating drug development in breast cancer: New frontiers for ER inhibition.
Cancer Treat Rev
; 109: 102432, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839531
10.
Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes.
Clin Breast Cancer
; 22(4): 319-325, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35074264
11.
Management of hormone receptor-positive, HER2-negative early breast cancer.
Semin Oncol
; 47(4): 187-200, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32546323
12.
Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study.
Cancers (Basel)
; 11(7)2019 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31319547
13.
Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways.
Oncotarget
; 8(46): 80568-80588, 2017 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29113326
14.
Review of Triple Negative Breast Cancer and the Impact of Inducible Nitric Oxide Synthase on Tumor Biology and Patient Outcomes.
Crit Rev Oncog
; 21(5-6): 333-351, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-29431082
15.
Molecular Tumor Board Guides Successful Treatment of a Rare, Locally Aggressive, Uterine Mesenchymal Neoplasm.
JCO Precis Oncol
; 52021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34250413
16.
Single agent anti PD-1 inhibitors in esophageal cancer-a first step in a new therapeutic direction.
J Thorac Dis
; 10(3): 1308-1313, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29707283